CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 5,320 shares at $21.72 ($116K) on 2016-12-30, disclosed to the SEC on 2017-01-04.
Open-market purchase of $116k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 2,510 | $55K | 47.2% |
| 2 | $21.72 | 2,810 | $61K | 52.8% |
| Total | $21.72 avg | 5,320 | $116K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |